An Wouters

3.1k total citations · 1 hit paper
73 papers, 2.2k citations indexed

About

An Wouters is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, An Wouters has authored 73 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 38 papers in Molecular Biology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in An Wouters's work include Cancer-related Molecular Pathways (17 papers), Lung Cancer Treatments and Mutations (17 papers) and Cancer, Hypoxia, and Metabolism (12 papers). An Wouters is often cited by papers focused on Cancer-related Molecular Pathways (17 papers), Lung Cancer Treatments and Mutations (17 papers) and Cancer, Hypoxia, and Metabolism (12 papers). An Wouters collaborates with scholars based in Belgium, Netherlands and United Kingdom. An Wouters's co-authors include Filip Lardon, Marc Peeters, Patrick Pauwels, Jan B. Vermorken, Bea Pauwels, Christophe Deben, Evelien Smits, Jorrit De Waele, Vanessa Deschoolmeester and Julie Jacobs and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Agricultural and Food Chemistry.

In The Last Decade

An Wouters

70 papers receiving 2.2k citations

Hit Papers

The potential and controversy of targeting STAT family me... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
An Wouters Belgium 27 1.1k 965 497 388 355 73 2.2k
Woonyoung Choi United States 18 1.5k 1.3× 1.3k 1.3× 668 1.3× 441 1.1× 285 0.8× 65 3.0k
Elisabeth Letellier Luxembourg 26 1.3k 1.2× 895 0.9× 726 1.5× 253 0.7× 444 1.3× 42 2.4k
Yunus A. Luqmani Kuwait 25 1.2k 1.1× 941 1.0× 606 1.2× 265 0.7× 184 0.5× 66 2.5k
Guocan Wang United States 20 1.6k 1.5× 862 0.9× 641 1.3× 542 1.4× 466 1.3× 33 2.6k
Vijay Pandey China 30 1.4k 1.3× 658 0.7× 706 1.4× 226 0.6× 281 0.8× 105 2.5k
Chao Chen China 29 1.4k 1.2× 817 0.8× 996 2.0× 320 0.8× 427 1.2× 130 2.7k
Germana Castelli Italy 29 1.6k 1.5× 798 0.8× 950 1.9× 478 1.2× 400 1.1× 97 3.1k
José M.A. Moreira Denmark 31 1.8k 1.7× 656 0.7× 670 1.3× 210 0.5× 239 0.7× 79 2.8k

Countries citing papers authored by An Wouters

Since Specialization
Citations

This map shows the geographic impact of An Wouters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Wouters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Wouters more than expected).

Fields of papers citing papers by An Wouters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Wouters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Wouters. The network helps show where An Wouters may publish in the future.

Co-authorship network of co-authors of An Wouters

This figure shows the co-authorship network connecting the top 25 collaborators of An Wouters. A scholar is included among the top collaborators of An Wouters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Wouters. An Wouters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wouters, An, et al.. (2025). Powering immunity: mitochondrial dynamics in natural killer cells. Trends in Molecular Medicine. 32(1). 49–64. 2 indexed citations
2.
Audenaerde, Jonas R.M. Van, Jorrit De Waele, Christophe Hermans, et al.. (2025). Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma. OncoImmunology. 14(1). 2512104–2512104.
3.
Siozopoulou, Vasiliki, Christophe Hermans, Hilde Lambrechts, et al.. (2022). The prognostic impact of the immune signature in head and neck squamous cell carcinoma. Frontiers in Immunology. 13. 1001161–1001161. 13 indexed citations
4.
Domen, Andreas, Delphine Quatannens, Sara Zanivan, et al.. (2021). Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. Cancers. 13(5). 987–987. 42 indexed citations
5.
Deben, Christophe, Laurie Freire Boullosa, Andreas Domen, et al.. (2021). Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells. Cancer Drug Resistance. 4(1). 233–243. 10 indexed citations
6.
Sorber, Laure, Peter A. van Dam, Geert Roeyen, et al.. (2020). The art of obtaining a high yield of cell-free DNA from urine. PLoS ONE. 15(4). e0231058–e0231058. 43 indexed citations
7.
Pauw, Ines De, Filip Lardon, Jolien Van den Bossche, et al.. (2019). Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib. Cancers. 11(1). 98–98. 14 indexed citations
8.
Bossche, Jolien Van den, Andreas Domen, Marc Peeters, et al.. (2019). Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status. Cancers. 11(12). 1893–1893. 9 indexed citations
9.
Krayem, Mohammad, Ahmad Najem, An Wouters, et al.. (2019). The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers. 11(8). 1093–1093. 20 indexed citations
10.
Deben, Christophe, Vanessa Deschoolmeester, Jorrit De Waele, et al.. (2018). Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress. Cancers. 10(4). 126–126. 46 indexed citations
11.
Bossche, Jolien Van den, Christophe Deben, Ken Op de Beeck, et al.. (2017). Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia. Journal of Cancer. 8(8). 1441–1452. 12 indexed citations
12.
Deben, Christophe, Ken Op de Beeck, Jolien Van den Bossche, et al.. (2017). MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients. Journal of Cancer. 8(12). 2154–2162. 4 indexed citations
13.
Vangestel, Christel, An Wouters, Patrick Pauwels, et al.. (2016). Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using 18 F-FDG PET/CT for Monitoring Treatment Response. Cancer Biotherapy and Radiopharmaceuticals. 31(3). 99–109. 13 indexed citations
14.
Steen, Nele Van Der, Christophe Deben, Vanessa Deschoolmeester, et al.. (2016). Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer. World Journal of Clinical Oncology. 7(6). 425–425. 9 indexed citations
15.
Boeckx, Carolien, Ken Op de Beeck, Ridha Limame, et al.. (2015). Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.. PubMed Central. 5(6). 1921–38. 24 indexed citations
16.
Wouters, An, et al.. (2015). In vitro and in vivo investigations on the antitumour activity of Chelidonium majus. Phytomedicine. 22(14). 1279–1287. 40 indexed citations
17.
Wouters, An, Bea Pauwels, Natalie Burrows, et al.. (2014). The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein. BMC Cancer. 14(1). 594–594. 7 indexed citations
18.
Boeckx, Carolien, Christine Weyn, Isabelle Vanden Bempt, et al.. (2014). Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response. BMC Research Notes. 7(1). 337–337. 27 indexed citations
19.
Szic, Katarzyna Szarc vel, Ken Op de Beeck, Dariusz Ratman, et al.. (2014). Pharmacological Levels of Withaferin A (Withania somnifera) Trigger Clinically Relevant Anticancer Effects Specific to Triple Negative Breast Cancer Cells. PLoS ONE. 9(2). e87850–e87850. 74 indexed citations
20.
Wouters, An, Bea Pauwels, Hilde Lambrechts, et al.. (2010). Counting clonogenic assays from normoxic and anoxic irradiation experiments manually or by using densitometric software. Physics in Medicine and Biology. 55(7). N167–N178. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026